Year Founded
2021
Ownership
Private
Stage
Commercial
Modalities
Antibody-based immunotherapyAutologous cell therapy

GenoBioTX General Information

Company provides genetically engineered mouse models and CRO services with over 9000 catalog mouse models and 600+ humanized mouse models

Contact Information

Website
Primary Industry
CRO
Corporate Office

Drug Pipeline

No pipeline data available

For full access to GenoBioTX's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

GenoBioTX Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view GenoBioTX's complete valuation and funding history, request access »

GenoBioTX Investors

Shanghai Model Organisms Center
Investor Type: Venture Capital
Holding: Minority